Back
AbCellera Biologics Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Buy
64
ABCL
AbCellera Biologics
Last Price:
3.90
Seasonality Move:
1.48%
Buy
52
AUPH
Aurinia Pharmaceuticals
Last Price:
5.08
Seasonality Move:
3.33%
Buy
64
AbCellera Biologics (ABCL)
is a Buy
Is AbCellera Biologics a Buy, Sell or Hold?
- The current AbCellera Biologics [ABCL] share price is $3.95. The Score for ABCL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ABCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.17. The Score for AUPH is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABCL Stock Price Chart
What is AbCellera Biologics's stock price today?
-
The AbCellera Biologics share price today is $3.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing slight buying pressure.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.17
The current trend is relatively stagnant and AUPH is experiencing slight buying pressure.
ABCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 45.33 | Sell |
| Chaikin Money Flow: | 207745 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.78 - 4.32) | Sell |
| Bollinger Bands (100): | (4.26 - 5.48) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 51.93 | Buy |
| Chaikin Money Flow: | 219902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.95 - 5.15) | Buy |
| Bollinger Bands (100): | (4.94 - 8.12) | Sell |
ABCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.93 | Buy |
| 20-day SMA: | 3.94 | Buy |
| 50-day SMA: | 4.37 | Sell |
| 200-day SMA: | 4.95 | Sell |
| 8-day EMA: | 3.94 | Buy |
| 20-day EMA: | 4.01 | Sell |
| 50-day EMA: | 4.31 | Sell |
| 200-day EMA: | 5.24 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.14 | Buy |
| 20-day SMA: | 5.05 | Buy |
| 50-day SMA: | 5.15 | Buy |
| 200-day SMA: | 7.61 | Sell |
| 8-day EMA: | 5.13 | Buy |
| 20-day EMA: | 5.1 | Buy |
| 50-day EMA: | 5.43 | Sell |
| 200-day EMA: | 7.18 | Sell |
AbCellera Biologics Earnings Growth & ABCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.05 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
AbCellera Biologics Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||